Susanne Clara Bard, UC San Diego Beyond the widespread attention GLP-1 drugs are receiving for treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease, emerging research is investigating their other potential impacts including their effects on aging
Q: How many time points do you use for metabolic stability assays
The underlying pharmacology, however, is category-wide: GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, plus the GIP/GLP-1 dual agonist tirzepatide
Growth hormone is part of this system as well, exerting a nuanced but crucially important effect in maintaining control of reproductive hormones
It is found throughout the body and plays a role in antioxidant activity and cellular processes involved in managing oxidative stress